פלודקאט ישראל - עברית - Ministry of Health

פלודקאט

unipharm trading ltd, israel - fluphenazine decanoate - תמיסה להזרקה - fluphenazine decanoate 25 mg/ml - fluphenazine - fluphenazine - management of psychotic disorders.

פריקאט ישראל - עברית - Ministry of Health

פריקאט

unipharm trading ltd, israel - haloperidol as decanoate - תמיסה להזרקה - haloperidol as decanoate 100 mg/ml - haloperidol - haloperidol - long term maintenance treatment of schizophrenia and mental or behaivoral problems.

טורבה 10 ישראל - עברית - Ministry of Health

טורבה 10

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 10 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טורבה 20 ישראל - עברית - Ministry of Health

טורבה 20

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 20 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טורבה 40 ישראל - עברית - Ministry of Health

טורבה 40

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 40 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

דופלקס 10160 ישראל - עברית - Ministry of Health

דופלקס 10160

unipharm ltd, israel - amlodipine as besilate; valsartan - טבליות מצופות - valsartan 160 mg; amlodipine as besilate 10 mg - valsartan

דופלקס 5160 ישראל - עברית - Ministry of Health

דופלקס 5160

unipharm ltd, israel - amlodipine as besilate; valsartan - טבליות מצופות - valsartan 160 mg; amlodipine as besilate 5 mg - valsartan

דופלקס 580 ישראל - עברית - Ministry of Health

דופלקס 580

unipharm ltd, israel - amlodipine as besilate; valsartan - טבליות מצופות - valsartan 80 mg; amlodipine as besilate 5 mg - valsartan

פרבליפ 10 ישראל - עברית - Ministry of Health

פרבליפ 10

unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 10 mg - pravastatin

פירון 267 ישראל - עברית - Ministry of Health

פירון 267

unipharm ltd, israel - pirfenidone - טבליה - pirfenidone 267 mg - pirfenidone